Home » pharmaceuticals industry » Piyush Goyal interacts with the captains of the Pharmaceutical industry and Associations

Piyush Goyal interacts with the captains of the Pharmaceutical industry and Associations

The Commerce and Industry Minister Shri Piyush Goyal today interacted with the captains of the Pharmaceutical industry, and Office-bearers of the Pharma Associations, through the Video Conference. The meeting was attended by the Ministers of State Shri H.S.Puri and Shri Som Parkash, Secretaries of the Department of Commerce, and Pharmaceuticals, and Officers from Departments of Commerce, Pharmaceuticals and Health.

During his interaction, Shri Goyal lauded the pharma industry for making India proud, by rising to the occasion during the Covid crisis. He said that India has been recognized as the ‘Pharmacy of the World’, as over 120 countries got some essential medicines, during the last two months, including 40 of them getting them in the form of grant, free of cost. He said that during the crisis, the officials of DGFT, MEA, Health and DoP burnt midnight oil to ensure that the export consignments are delivered at the earliest. The whole world appreciated India’s gesture, and this has swelled India’s goodwill and reputation. He said that India had adequate production capacity and abundant stock of HCQ and PCM for its projected domestic requirements, and putting restrictions on their exports was to ensure that the medicines are made available to all the needy nations, and no unscrupulous element stocks them for unwarranted gains.

The Pharma industry received accolades from the Minister for their extra-ordinary performance, in ensuring that the Country did not face any type of shortage of medicines during this period.  Shri Goyal said that early announcement of the Lockdown helped the country in preventing and containing the scourge of pandemic, and also scaling up the health infrastructure and build capacity, besides generating awareness among the people about the precautions and preventive measures. He said that India has set an example, under the able guidance and leadership of the Prime Minister Shri Narendra Modi, in being pro-active in management of Covid-19, and also following it up with welfare and relief packages for mitigating its consequences.

Shri Goyal assured the industry that the Government will fully support the industry in its expansion, diversification and strengthening. He said that the industry has an important role to play in the Aatamnirbhar Bharat campaign. The country should become Aatmanirbhar in APIs as early as possible, as the government has taken a number of steps in this regard. It has already approved the scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks. Also, Production Linked Incentive Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country has been given a go ahead.

The Minister said that anti-dumping investigation process has been expedited. The Minister said that in case of ongoing bilateral FTAs, if any roadblock or unfair competition is being noticed, the Government may be informed and prompt remedial action will be taken. He said they should look at large untapped market in Eastern Europe and Russia. Calling upon a collaborative route in the R&D efforts, Shri Goyal said the Academicians, Universities, ICMR and private sector should join hands. Informing the gathering that the Government has decided to disinvest in certain Pharma PSUs, the Minister invited the Indian companies to use PSUs for plug and play model of manufacturing. The Minister assured the industry that all suggestions presented in the meeting will be quickly examined and wherever required, the inter-ministerial consultations will be completed at the earliest.

About Indianindustry Media

Leave a Reply

Your email address will not be published. Required fields are marked *



Check Also

Uniform Code of Pharmaceutical Marketing Practices

The Government has put in place a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for ...

CCI releases key findings and observations on Market Study on Pharmaceuticals Sector in India

The Competition Commission of India (CCI) has released here today a report titled ‘Market Study on ...

Details of number of pharmaceutical drug manufacturers in States/UTs

As per Central Drugs Standard Control Organisation (CDSCO), the details of number of pharmaceutical drug ...

Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and APIs in the country

With an objective to attain self-reliance and reduce import dependence in these critical Bulk Drugs ...

Union Chemicals & Fertilizers Minister inaugurates a four day Global Investors meet: India Pharma 2021 & India Medical Devices 2021

Union Chemicals and Fertilizers Minister Shri D V Sadananda Gowda inaugurated a four day Global ...

Cabinet approves Production Linked Incentive Scheme for Pharmaceuticals

The Union Cabinet, chaired by the Prime Minister, Shri Narendra Modi has approved Production Linked ...

Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and APIs

The Applications of following companies, which have committed more than the minimum proposed annual production ...

Union Pharma Secretary Holds VC with representatives of Drugs and Pharma Industry and their Associations.

Indian Pharma industry is producing enough stocks of essential medicines particularly HCQ to meet both ...

Ceremony held for award of contract of coal gasification plant for urea project at Talcher

Contract signing award ceremony for Coal gasification unit for production of Urea and Ammonia at ...

Pharmaceutical and Export Promotion Council 

Pharmaceutical Export Promotion Council of India (Pharmexcil) was set up by the Ministry of Commerce ...

WP2Social Auto Publish Powered By : XYZScripts.com